
NCCN Enhances ctDNA Guidance for Colon, Rectal, and Merkel Cell Cancers
NCCN Enhances ctDNA Guidance for Colon, Rectal, and Merkel Cell Cancers Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, has recently commented on the updated guidelines by the National Comprehensive Cancer Network (NCCN) regarding circulating…












